Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) Sees Large Growth in Short Interest

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) was the recipient of a large growth in short interest in October. As of October 15th, there was short interest totaling 195,736 shares, a growth of 191.6% from the September 30th total of 67,129 shares. Based on an average trading volume of 515,895 shares, the short-interest ratio is presently 0.4 days. Approximately 1.2% of the company’s stock are sold short.

Analyst Ratings Changes

Separately, Weiss Ratings lowered Hong Kong Pharma Digital Technology from a “sell (d)” rating to a “sell (e+)” rating in a research report on Thursday, August 13th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Hong Kong Pharma Digital Technology currently has an average rating of “Sell”.

Hong Kong Pharma Digital Technology Price Performance

NASDAQ:HKPD traded up $0.03 during mid-day trading on Thursday, hitting $2.21. 9,035 shares of the company’s stock were exchanged, compared to its average volume of 68,521. The business has a fifty day moving average price of $3.28 and a 200 day moving average price of $9.52. Hong Kong Pharma Digital Technology has a one year low of $1.63 and a one year high of $29.00. The company has a current ratio of 3.86, a quick ratio of 3.75 and a debt-to-equity ratio of 0.01.

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) last posted its quarterly earnings data on Friday, August 7th. The company reported ($0.82) earnings per share for the quarter. The company had revenue of $3.15 million during the quarter.

Hong Kong Pharma Digital Technology Company Profile

Hong Kong Pharma is an exempted limited liability company formed under the laws of the Cayman Islands on August 17, 2023. As a holding company with no material operations of its own, Hong Kong Pharma conducts its operations through its wholly owned subsidiaries, Joint Cross Border Logistics Company Limited and V-Alliance Technology Supplies Limited, each a limited liability corporation incorporated in Hong Kong and collectively referred to as HK Subsidiaries. Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division.